analysis of variance AS ankylosing spondylitis BSA body surface area CCP cyclic citrullinated peptide CI confidence interval CRP C-reactive protein CSR Clinical Study Report Disease Activity Score including evaluation of 28 joints DAS28 (CRP) Disease Activity including evaluation of 28 joints and CRP DIP distal interphalangeal DMARD disease-modifying anti-rheumatic drug EE escape EU European ECLIA electrochemiluminescent immunoassay GI gastrointestinal GO gross osteolysis HAQ Health Assessment Questionnaire Hgb haemoglobin ITT intention to JSN joint space narrowing LFT liver function test LLOQ lower limit of quantification mAb monoclonal antibody MASES Maastricht AS Enthesitis Score MCS mental component summary
analysis of variance AS ankylosing spondylitis BSA body surface area CCP cyclic citrullinated peptide CI confidence interval CRP C-reactive protein CSR Clinical Study Report Disease Activity Score including evaluation of 28 joints DAS28 (CRP) Disease Activity including evaluation of 28 joints and CRP DIP distal interphalangeal DMARD disease-modifying anti-rheumatic drug EE escape EU European ECLIA electrochemiluminescent immunoassay GI gastrointestinal GO gross osteolysis HAQ Health Assessment Questionnaire Hgb haemoglobin ITT intention to JSN joint space narrowing LFT liver function test LLOQ lower limit of quantification mAb monoclonal antibody MASES Maastricht AS Enthesitis Score MCS mental component summary
auspar-golimumab-130816-cer.docx